Verastem Inc (VSTM)
5.90
-0.64
(-9.79%)
USD |
NASDAQ |
Jan 08, 16:00
5.80
-0.10
(-1.69%)
After-Hours: 20:00
Verastem SG&A Expense (Quarterly): 12.28M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 133.29M |
| CytomX Therapeutics Inc | 7.953M |
| Applied Therapeutics Inc | 15.04M |
| Poseida Therapeutics Inc | 10.09M |
| Reviva Pharmaceuticals Holdings Inc | 1.604M |